Table 1.
Baseline characteristics of interview participants
| Participant | Age, years | Sex | H&Y | Duration of PD (years) | MoCA | HADS
|
LEDD (mg) | PD drugs | Daily doses | |
|---|---|---|---|---|---|---|---|---|---|---|
| Anxiety | Depression | |||||||||
| 1 | 56 | Male | 3 | 7 | 25 | 6 | 11 | 640 | 1 | 4 |
| 2 | 69 | Male | 2 | 7 | 28 | 6 | 3 | 740 | 2 | 7 |
| 3 | 72 | Female | 1 | 2 | 18 | 10 | 6 | 1,038 | 2 | 4 |
| 4 | 63 | Male | 3 | 4 | 27 | 5 | 2 | 1,758 | 4 | 12 |
| 5 | 71 | Female | 3 | 14 | 26 | 4 | 5 | 2,319 | 5 | 18 |
| 6 | 68 | Female | 1 | 6 | 30 | 4 | 3 | 247.5 | 2 | 4 |
| 7 | 72 | Female | 4 | 14 | 25 | 9 | 7 | 900 | 3 | 9 |
| 8 | 87 | Female | 0 | 2 | 24 | 3 | 1 | 187.5 | 1 | 3 |
| 9 | 80 | Female | 3 | 2 | 28 | 8 | 7 | 312.5 | 2 | 5 |
| 10 | 53 | Female | 1 | 8 | 27 | 13 | 10 | 480 | 3 | 13 |
Abbreviations: H&Y, Hoehn and Yahr; MoCA, Montreal Cognitive Assessment Scale; HADS, Hospital Anxiety and Depression Scale; LEDD, levodopa equivalent daily doses; PD, Parkinson’s disease.